Moomoo AI 已提取核心信息
On December 31, 2023, Sera Prognostics, Inc., a company specializing in high-risk pregnancy testing solutions, was the subject of a Schedule 13G filing with the United States Securities and Exchange Commission (SEC). The filing indicated that InterWest Partners X, LP (IWP X), along with its general partner InterWest Management Partners X, LLC (IMP X), and individual reporting persons Keval Desai, Gilbert H. Kliman, and Khaled A. Nasr, collectively reported ownership of 126,258 shares of Sera Prognostics' Class A Common Stock, which includes shares issuable upon the exercise of warrants. This represents approximately 0.4% of the company's Class A and B Common Stock, based on the number of shares outstanding as reported in the company's Form 10-Q filed on November 8, 2023. The filing was made under Rule 13d-1(c), indicating a passive investment position, and was signed on January 19, 2024, by Karen A. Wilson, Attorney-in-Fact for the reporting persons.
On December 31, 2023, Sera Prognostics, Inc., a company specializing in high-risk pregnancy testing solutions, was the subject of a Schedule 13G filing with the United States Securities and Exchange Commission (SEC). The filing indicated that InterWest Partners X, LP (IWP X), along with its general partner InterWest Management Partners X, LLC (IMP X), and individual reporting persons Keval Desai, Gilbert H. Kliman, and Khaled A. Nasr, collectively reported ownership of 126,258 shares of Sera Prognostics' Class A Common Stock, which includes shares issuable upon the exercise of warrants. This represents approximately 0.4% of the company's Class A and B Common Stock, based on the number of shares outstanding as reported in the company's Form 10-Q filed on November 8, 2023. The filing was made under Rule 13d-1(c), indicating a passive investment position, and was signed on January 19, 2024, by Karen A. Wilson, Attorney-in-Fact for the reporting persons.
2023年12月31日，专门从事高风险妊娠试验解决方案的公司Sera Prognostics, Inc. 成为向美国证券交易委员会 (SEC) 提交的附表13G文件的主体。文件显示，InterWest Partners X, LP（IWP X）及其普通合伙人InterWest Management Partners X, LLC（IMP X）和个人申报人凯瓦尔·德赛、吉尔伯特·克里曼和哈立德·纳斯尔共同报告了Sera Prognostics的126,258股A类普通股的所有权，其中包括行使认股权证时可发行的股份。根据该公司在2023年11月8日提交的10-Q表中报告的已发行股票数量，这约占该公司A类和B类普通股的0.4％。该文件是根据第13d-1（c）条提交的，表明了被动投资头寸，由申报人的事实律师凯伦·威尔逊于2024年1月19日签署。
2023年12月31日，专门从事高风险妊娠试验解决方案的公司Sera Prognostics, Inc. 成为向美国证券交易委员会 (SEC) 提交的附表13G文件的主体。文件显示，InterWest Partners X, LP（IWP X）及其普通合伙人InterWest Management Partners X, LLC（IMP X）和个人申报人凯瓦尔·德赛、吉尔伯特·克里曼和哈立德·纳斯尔共同报告了Sera Prognostics的126,258股A类普通股的所有权，其中包括行使认股权证时可发行的股份。根据该公司在2023年11月8日提交的10-Q表中报告的已发行股票数量，这约占该公司A类和B类普通股的0.4％。该文件是根据第13d-1（c）条提交的，表明了被动投资头寸，由申报人的事实律师凯伦·威尔逊于2024年1月19日签署。
有用
没用